Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study.

Journal of the American Academy of Dermatology
Christina L BoullIrene Lara-Corrales

Abstract

Treatment with BRAF inhibitors (BRAFI) and MEK inhibitors (MEKI) causes cutaneous reactions in children, limiting dosing or resulting in treatment cessation. The spectrum and severity of these reactions is not defined. To determine the frequency and spectrum of cutaneous reactions in children receiving BRAFI and MEKI and their effects on continued therapy. A multicenter, retrospective study was conducted at 11 clinical sites in the United States and Canada enrolling 99 children treated with BRAFI and/or MEKI for any indication from January 1, 2012, to January 1, 2018. All children in this study had a cutaneous reaction; most had multiple, with a mean per patient of 3.5 reactions on BRAFI, 3.7 on MEKI, and 3.4 on combination BRAFI/MEKI. Three patients discontinued treatment because of a cutaneous reaction. Treatment was altered in 27% of patients on BRAFI, 39.5% on MEKI, and 33% on combination therapy. The cutaneous reactions most likely to alter treatment were dermatitis, panniculitis, and keratosis pilaris-like reactions for BRAFI and dermatitis, acneiform eruptions, and paronychia for MEKI. Cutaneous reactions are common in children receiving BRAFI and MEKI, and many result in alterations or interruptions in oncologic therapy...Continue Reading

References

Jun 1, 1995·The British Journal of Dermatology·M S Lewis-Jones, A Y Finlay
Jun 1, 1994·The British Journal of Dermatology·L Poskitt, J D Wilkinson
Feb 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Udai BanerjiCarla M L van Herpen
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Nov 22, 2011·Acta Dermato-venereologica·Adam ReichJacek C Szepietowski
May 1, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·I ManousaridisJ Utikal
May 23, 2012·Journal of the American Academy of Dermatology·Emily Y ChuMisha Rosenbach
Sep 4, 2012·Journal of the American Academy of Dermatology·Kevin P BoydLauren C Hughey
Dec 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin B KimKarl D Lewis
Feb 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L BoussemartC Robert
Mar 5, 2013·The Oncologist·Mario E LacoutureAndrew K Joe
Jul 25, 2013·International Journal of Dermatology·Jonathan L CurryVictor G Prieto
Dec 10, 2013·The Australasian Journal of Dermatology·Rachael AnforthPablo Fernandez-Peñas
May 21, 2014·Nature Reviews. Clinical Oncology·Yujie Zhao, Alex A Adjei
Jul 20, 2014·Journal of the American Academy of Dermatology·Claire Marie Reyes-Habito, Ellen K Roh
Dec 3, 2014·Journal of the American Academy of Dermatology·Martina SanlorenzoSusana Ortiz-Urda
Feb 28, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G R BlumenscheinP A Jänne
Mar 10, 2015·Journal of the American Academy of Dermatology·Rachael AnforthPablo Fernandez-Peñas
Mar 11, 2015·Therapeutic Advances in Medical Oncology·Sarah J Welsh, Pippa G Corrie
Mar 28, 2017·The Journal of Investigative Dermatology·Alicia SfecciLise Boussemart
Mar 27, 2018·Pediatric Dermatology·Trisha BhatCarrie C Coughlin
Mar 2, 2019·Pediatric Blood & Cancer·Hannah SongJennifer T Huang

❮ Previous
Next ❯

Citations

Aug 28, 2021·Dermatopathology·Isabelle Moulonguet, Sylvie Fraitag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.